Fred Callori
CEO, co-founder · Neurosterix · Geneva, Switzerland
Biotechnology · Series B · Founded 2024
Latest raise
$105M
Date raised
November 11, 2026
Round
Series B
About Fred Callori
a clinical-stage biotechnology company focused on transforming neuropsychiatric care through selective allosteric modulation
- Who is Fred Callori?
- Fred Callori is listed as CEO, co-founder of Neurosterix, a biotechnology company founded in 2024 based in Geneva, Switzerland.
- How much did Neurosterix raise?
- Neurosterix raised $105M in a Series B round on November 11, 2026 (2 days ago). Backed by RTW Investments.
Get newly funded founders every week
A free weekly list of startups that just raised.